uniQure N.V’s recent filing unveils that its Chief Medical Officer Abi-Saab Walid unloaded Company’s shares for reported $20407.0 on Jun 27 ’25. In the deal valued at $13.92 per share,1,466 shares were sold. As a result of this transaction, Abi-Saab Walid now holds 150,437 shares worth roughly $2.18 million.
Then, Springhorn Jeremy P. sold 2,112 shares, generating $30,518 in total proceeds. Upon selling the shares at $14.45, the Director now owns 37,694 shares.
Before that, POST LEONARD E sold 2,112 shares. uniQure N.V shares valued at $30,518 were divested by the Director at a price of $14.45 per share. As a result of the transaction, POST LEONARD E now holds 29,937 shares, worth roughly $0.43 million.
A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in early December from “an Outperform” to “a Strong buy”. Goldman revised its rating on February 29, 2024. It rated QURE as “a Neutral” which previously was an “a Buy”.
Price Performance Review of QURE
On Monday, uniQure N.V [NASDAQ:QURE] saw its stock fall -3.27% to $14.5. Over the last five days, the stock has lost -0.34%. uniQure N.V shares have risen nearly 71.19% since the year began. Nevertheless, the stocks have fallen -17.89% over the past one year.
How much short interest is there in uniQure N.V?
A steep rise in short interest was recorded in uniQure N.V stocks on 2025-06-13, growing by 0.63 million shares to a total of 7.67 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 7.04 million shares. There was a rise of 8.17%, which implies that there is a positive sentiment for the stock.
